March 14 (Reuters) - Reckitt said on Friday a

circuit court in the United States had ruled that a new trial

could be sought by plaintiffs in a case that accused the

London-listed firm and Abbott of failing to warn of the

risks of premature-infant formulas.

The Thursday's ruling comes after a St. Louis, Missouri

state court last October found Reckitt unit Mead Johnson and

Abbott not responsible for a young boy's debilitating intestinal

disease.